湖州亚瑟制药

Arthur Pharmaceutical is a China-based pharmaceutical company specializing in the development and manufacturing of high-end generic drugs and complex formulations for global markets. Founded in 2020 by industry veterans, the company focuses on therapeutic areas such as cardiovascular health, the central nervous system, and anti-infectives. Arthur Pharmaceutical operates state-of-the-art R&D and GMP-compliant manufacturing facilities in Huzhou, Zhejiang, designed to meet U.S. FDA and China NMPA standards. The company has successfully secured multiple Abbreviated New Drug Application (ANDA) approvals, demonstrating its capability in high-barrier drug development. Its business model integrates research, production, and sales to provide affordable, high-quality medicine globally. The firm is backed by prominent investors including Qiming Venture Partners and Hillhouse Capital.